EAM
Eventide Asset Management Portfolio holdings
AUM
$5.71B
This Quarter Return
+52.23%
1 Year Return
+51.18%
3 Year Return
+209.28%
5 Year Return
+283.63%
10 Year Return
+1,480.39%
AUM
$4.46B
AUM Growth
+$4.46B
(+49%)
Cap. Flow
+$210M
Cap. Flow
% of AUM
4.7%
Top 10 Holdings %
Top 10 Hldgs %
30.17%
Holding
145
New
24
Increased
36
Reduced
22
Closed
11
Top Buys
| 1 |
Pliant Therapeutics
PLRX
|
$88.4M |
| 2 |
Zentalis Pharmaceuticals
ZNTL
|
$42.5M |
| 3 |
Trane Technologies
TT
|
$40.2M |
| 4 |
Exact Sciences
EXAS
|
$30.3M |
| 5 |
Fiverr
FVRR
|
$29.4M |
Top Sells
| 1 |
Twilio
TWLO
|
$65.6M |
| 2 |
Xylem
XYL
|
$51.6M |
| 3 |
ZGNX
Zogenix, Inc.
ZGNX
|
$44M |
| 4 |
Varonis Systems
VRNS
|
$26.7M |
| 5 |
SAGE
Sage Therapeutics
SAGE
|
$22.7M |
Sector Composition
| 1 | Healthcare | 46.53% |
| 2 | Technology | 23.12% |
| 3 | Industrials | 9.16% |
| 4 | Consumer Discretionary | 7.54% |
| 5 | Communication Services | 3.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Ascendis Pharma
ASND
$11.8B
| $253M | 5.5% | 1,709,848 +11,200 | +0.7% | +$1.66M |
|
2
Sarepta Therapeutics
SRPT
$1.78B
| $160M | 3.47% | 996,000 | – | – |
|
|
3
Exact Sciences
EXAS
$8.98B
| $151M | 3.29% | 1,740,000 +348,000 | +25% | +$30.3M |
|
|
BHVN
4
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $130M | 2.83% | 1,783,761 | – | – |
|
5
FIVE9
FIVN
$2.08B
| $127M | 2.77% | 1,151,000 -67,000 | -6% | -$7.41M |
|
6
Trade Desk
TTD
$26.7B
| $122M | 2.65% | 300,000 | – | – |
|
7
Wayfair
W
$9.67B
| $113M | 2.46% | 573,000 | – | – |
|
|
KRTX
8
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $100M | 2.18% | 901,077 | – | – |
|
9
CrowdStrike
CRWD
$106B
| $99M | 2.15% | 987,000 | – | – |
|
10
Roper Technologies
ROP
$56.6B
| $90.2M | 1.96% | 232,400 +18,400 | +9% | +$7.14M |
|
|
11
Pliant Therapeutics
PLRX
$101M
| $88.4M | 1.92% | +2,838,125 | New | +$88.4M |
|
|
12
Twilio
TWLO
$16.2B
| $84.7M | 1.84% | 386,000 -299,000 | -44% | -$65.6M |
|
13
Lowe's Companies
LOW
$145B
| $81.1M | 1.76% | 599,900 +3,300 | +0.6% | +$446K |
|
|
SPLK
14
DELISTED
Splunk Inc
SPLK
| $75.5M | 1.64% | 380,000 -48,000 | -11% | -$9.54M |
|
15
Waste Connections
WCN
$47.5B
| $75.4M | 1.64% | 804,000 | – | – |
|
16
Dynatrace
DT
$15.3B
| $75.1M | 1.63% | 1,849,500 -226,900 | -11% | -$9.21M |
|
17
Mettler-Toledo International
MTD
$26.8B
| $73.3M | 1.59% | 91,000 +20,000 | +28% | +$16.1M |
|
18
Pool Corp
POOL
$11.6B
| $67.8M | 1.47% | 249,200 +63,200 | +34% | +$17.2M |
|
19
Lam Research
LRCX
$127B
| $65M | 1.41% | 201,000 | – | – |
|
|
XIFR
20
XPLR Infrastructure, LP
XIFR
$996M
| $64.5M | 1.4% | 1,258,100 +15,300 | +1% | +$785K |
|
21
ASML
ASML
$292B
| $63.3M | 1.38% | 172,000 | – | – |
|
|
MYOK
22
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $60M | 1.3% | 621,000 | – | – |
|
23
argenx
ARGX
$43.6B
| $59.5M | 1.29% | 264,000 -33,300 | -11% | -$7.5M |
|
24
Lennox International
LII
$19.6B
| $59.4M | 1.29% | 255,000 | – | – |
|
25
Idexx Laboratories
IDXX
$51.8B
| $58.1M | 1.26% | 176,000 +33,000 | +23% | +$10.9M |
|